LSV Asset Management’s Utah Medical Products UTMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$738K Buy
12,974
+1,053
+9% +$59.9K ﹤0.01% 634
2025
Q1
$668K Buy
11,921
+1,700
+17% +$95.3K ﹤0.01% 661
2024
Q4
$628K Sell
10,221
-3,600
-26% -$221K ﹤0.01% 651
2024
Q3
$925K Hold
13,821
﹤0.01% 644
2024
Q2
$923K Hold
13,821
﹤0.01% 685
2024
Q1
$983K Sell
13,821
-2,623
-16% -$187K ﹤0.01% 686
2023
Q4
$1.39M Sell
16,444
-2,771
-14% -$233K ﹤0.01% 656
2023
Q3
$1.65M Sell
19,215
-1,400
-7% -$120K ﹤0.01% 635
2023
Q2
$1.92M Sell
20,615
-3,885
-16% -$362K ﹤0.01% 629
2023
Q1
$2.32M Buy
24,500
+11,686
+91% +$1.11M 0.01% 591
2022
Q4
$1.29M Buy
12,814
+1,913
+18% +$192K ﹤0.01% 630
2022
Q3
$930K Sell
10,901
-1,799
-14% -$153K ﹤0.01% 652
2022
Q2
$1.09M Sell
12,700
-400
-3% -$34.4K ﹤0.01% 664
2022
Q1
$1.18M Buy
+13,100
New +$1.18M ﹤0.01% 689